Published in Law and Health Weekly, March 27th, 2004
The patent, titled "Vasopermeability-Enhancing Conjugates," further expands Peregrine's patent coverage for general concepts of using agents that localize to tumors and induce tumor blood vessels to become more permeable in order to make chemotherapy drugs and diagnostic agents more effective.
Vasopermeation enhancement agents are sensitizing agents that enhance the effectiveness of cancer therapy or diagnosis by allowing a greater amount of an administered drug or diagnostic agent to reach the target...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.